Lensar (LNSR) EBIT Margin Growth (1y) (2020 - 2026)
Lensar (LNSR) EBIT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.43 Bn | 193.83 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 126.52 Bn | 123.04 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 52.20 Bn | 47.95 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn | 146.00 |
| 10 | Lensar | 102.80 Mn | 89.24 Mn | 9.78 Mn | 5,807.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5,807.00 |
| Mar 31, 2026 | 5,757.00 |
| Dec 31, 2025 | -3,918.00 |
| Sep 30, 2025 | -4,889.00 |
| Jun 30, 2025 | -175.00 |
| Mar 31, 2025 | 94,187.00 |
| Dec 31, 2024 | 1,417.00 |
| Sep 30, 2024 | 1,413.00 |
| Jun 30, 2024 | -2,164.00 |
| Mar 31, 2024 | -92,991.00 |
| Dec 31, 2023 | 218.00 |
| Sep 30, 2023 | 2,803.00 |
| Jun 30, 2023 | 7,486.00 |
| Mar 31, 2023 | 1,870.00 |
| Dec 31, 2022 | 449.00 |
| Sep 30, 2022 | 3,554.00 |
| Jun 30, 2022 | -3,813.00 |
| Mar 31, 2022 | 1,611.00 |
| Dec 31, 2021 | 11,137.00 |
| Sep 30, 2021 | -1,063.00 |